(Q38150697)

29 August 2017

Glucose intolerance states in women with the polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

29 August 2017

1 reference

1 reference

1 reference

R Pasquali

1

1 reference

PubMed ID

24105073

29 August 2017

A Gambineri

series ordinal

2

1 reference

29 August 2017

1 September 2013

1 reference

Journal of Endocrinological Investigation

29 August 2017

1 reference

29 August 2017

36

1 reference

29 August 2017

8

1 reference

29 August 2017

648-653

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03346757

29 August 2017

0 references

cites work

Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

PCOS Forum: research in polycystic ovary syndrome today and tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Targeting insulin sensitivity in the treatment of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

The impact of obesity on reproduction in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Glucose intolerance in Japanese patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Assessment of impaired glucose tolerance prevalence with hemoglobin A₁c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Genetics of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

FTO gene polymorphisms and obesity risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Sex hormone-binding globulin and risk of type 2 diabetes in women and men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Sex hormone binding globulin and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Menstrual patterns and risk of adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Menstrual cycle characteristics and risk of coronary heart disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346757

Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones

21 January 2018

1 reference

12 December 2020

Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome

1 reference

12 December 2020

Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus

1 reference

12 December 2020

High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.

1 reference

12 December 2020

Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes

1 reference

12 December 2020

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

12 December 2020

Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

1 reference

12 December 2020

1 reference

12 December 2020

Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome.

1 reference

12 December 2020

Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up

1 reference

12 December 2020

Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03346757

1 reference

PubMed ID

24105073

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

24105073